Cancer Risk Slightly Higher For Women In Discontinued Hormone Tr...

Courtesy ScienceDaily Thu, 03/06/2008 - 22:00

A follow up study of participants in the Women's Health Initiative clinical trial has found that women who were taking the combined hormone therapy of estrogen plus progestin may have an increased risk of cancer since the intervention was stopped, compared to participants in the trial's placebo group.

More related items

Hormone Therapy In Postmenopausal Women Associated...
Postmenopausal women taking hormone therapy appear to have an increased risk of stroke regardless of when they started treatment, according to a new report. Compared to women who had never...

Hormone Replacement Therapy Appears To Have No Effect...
Although rheumatoid arthritis (RA) is more predominant in women, the reasons for this are unclear. Many studies have examined the effects of estrogen on the risk and severity of RA, but the...

Genetic predictors of esophageal cancer identified
(American Association for Cancer Research) Researchers have identified 11 genotypes that may increase esophageal cancer risk, according to research published in the November issue of Cancer...

Soapmaker's Companion: A Comprehensive Guide with...
Basic soapmaking instruction and specialty techniques like marbling, layering, and making transparent and liquid soaps.

The Black Hole War: My Battle with Stephen Hawking to...
What happens when something is sucked into a black hole? Does it disappear? Three decades ago, a young physicist named Stephen Hawking claimed it did-and in doing so put at risk everything we...